# Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer

> **NCT01356030** · NA · COMPLETED · sponsor: **California Pacific Medical Center Research Institute** · enrollment: 51 (actual)

## Conditions studied

- Pancreaticobiliary Cancers
- Jaundice
- Bile Duct Obstruction

## Interventions

- **PROCEDURE:** ERCP
- **PROCEDURE:** EUS FNA

## Key facts

- **NCT ID:** NCT01356030
- **Lead sponsor:** California Pacific Medical Center Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2013-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01356030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01356030, "Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01356030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
